Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)

Not yet recruitingOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2035

Conditions
Steatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Steatotic Liver Disease of Mixed Origin (MetALD)ALD - Alcoholic Liver Disease
Trial Locations (4)

66421

University Medical Center Saarland, Department of Internal Medicine II, Homburg

75013

Hôpital de la Pitié Salpêtrière, Paris

Unknown

Division of Gastroenterology, Department of Medical Sciences, University of Turin, Turin

NE2 4HH

Translational & Clinical Research Institute Faculty of Medical Sciences, Newcastle upon Tyne

All Listed Sponsors
collaborator

Universitatsmedizin Mainz - 1. Medizinische Klinik

OTHER

collaborator

Newcastle University

OTHER

collaborator

Barcelona Institute for Global Health

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

collaborator

University of Turin, Italy

OTHER

lead

Universität des Saarlandes

OTHER

NCT06907563 - Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study) | Biotech Hunter | Biotech Hunter